feed,title,long_url,short_url
Benzinga,Bio-Path Stock Is Trading Higher As Prexigebersen Triplet Combo Shows Favorable Safety Profile In Acute Myeloid Leukemia Study,https://benzinga.com/general/biotech/21/04/20478235/bio-path-stock-is-trading-higher-as-prexigebersen-triplet-combo-shows-favorable-safety-profile-in,https://j.mp/2Q0TKeU
